The objective of this study was to review the development of a multidisciplinary asthma disease management program in a large medical group practice in an urban area, and evaluate the impact of the program on processes of care and health care utilization for adults and children with asthma. The disease management intervention included the development of a patient registry, a systematic approach to assessment of asthma control using the Asthma Therapy Assessment Questionnaire (ATAQ), case management, and physician education. 
INTRODUCTION

A
STHMA is a chronic inflammatory disorder of the airways characterized by episodic and reversible symptoms of airflow limitation. Recent estimates show that it affects more than 14 million people in the United States. 1 Direct and indirect costs associated with asthma in the United States account for an estimated $11.3 billion per year. 2 Proper control of this condition requires the correct diagnosis, appropriate classification of severity, optimal use of medications, the use of written treatment plans, and planning for crisis intervention. 3 Recent studies suggest that many aspects of asthma therapy remain inad-equate. [4] [5] [6] Studies in diverse settings have consistently shown that controller medications are underused, and few patients have the tools needed for self-management, such as peak flow meters and written treatment plans. [7] [8] [9] It is thought that many of these deficiencies are related to barriers that are systemic or organizational, 10 thus making asthma a frequent focus for disease management initiatives. 11 Disease management has been succinctly defined as "the use of an explicit systematic populationbased approach to identify persons at risk, intervene with specific programs of care, and measure clinical and other outcomes." 12 Despite the belief that asthma is a promising target for successful disease management, there are relatively few published studies demonstrating the effectiveness of comprehensive asthma disease management programs in improving outcomes across a population. [13] [14] [15] [16] Advocate Health Centers (AHC) is a large medical group practice with 16 sites located throughout the Chicago metropolitan area. The centers served more than 200,000 patients in 2001, with 72% covered by full risk contracts, 22% partial risk, and 6% fee-for-service. The population served is multi-ethnic, but predominantly African-American patients of lower socioeconomic status.
In 1999, the AHC Asthma Project was initiated. The broad goals of the program were to improve quality of life, reduce complications related to asthma, and improve patient satisfaction with care and services. The project included diverse activities, with focus on enhancing patient and clinician education, developing the Asthma Specialist role, and documenting and evaluating outcomes.
The purpose of this paper is to review the development of the AHC Asthma Project and evaluate the outcomes of the project as of 2001 by presenting population data collected over 1 year at baseline and after 1 year of activities.
MATERIALS AND METHODS
Project planning and implementation
By 1999, AHC leadership had clearly recognized the need to optimize patient care for asthma. Review of published local health department data and morbidity analyses within the practice confirmed that asthma was one of the most common reasons for hospitalization, emergency department (ED), and outpatient visits. Asthma was established as one of three highest clinical management priority areas for 1999-2000.
In early 1999, an asthma task force was established. This included the medical director and department director for quality improvement, the chairs of the departments of medicine and pediatrics, the head of allergy and immunology, a designated nurse quality improvement specialist, the vice-president of operations, and an office practice nurse who was also an asthma patient. The information systems, contracting and finance departments were also charged with providing requested support.
A literature review was conducted by task force members with over 50 seminal articles analyzed to assess benchmarks and proven interventions. In addition to the literature review, several internal observations were considered in developing objectives to achieve the project goals.
Need for provider education. In a study of 238 medical records of patients with the diagnosis of asthma, 50 were found to have had an office visit for an acute exacerbation within a one year time frame of review. Of these only 54% were recommended treatment with any form of steroid. In a subsequent medical record audit of 400 asthmatics designed to assess chronic care practices, only 9% had documentation of the patient being provided a home treatment plan or instructions for self-management.
Need for more patient education. Nurses and physicians were surveyed at Medical Center and Quality Improvement (QI) committee meetings to assess their perception of patient education deficits. They consistently noted that many patients who had been hospitalized or seen in an emergency department demonstrated poor inhaler medication use techniques, were "non-compliant" with medications and had little understanding of the need to avoid asthma "triggers."
Barriers to patient care regarding use of durable medical equipment. Patients seen in the office for exacerbations or otherwise poor control of asthma were often given nebulizer treatments and then a prescription to obtain spacers, nebulizers, and peak flow meters for self management. Physicians were concerned about the time and teaching opportunity that was lost for patients in order to obtain these from durable medical equipment suppliers. Since most insurance companies covered these items as benefits, this step was viewed as an unnecessary administrative obstacle.
Need for population management. Before formal prioritization of asthma as an organizational clinical priority, case management services had been provided to patients who had been repeatedly hospitalized for asthma with the intent of focusing such resources on the highest "utilizers." Case management was provided by nurses with no formal training in asthma care or patient education. Since no formal objective assessments were conducted, it was difficult to assess the impact of this deficit in training. However, asthma remained a common cause for hospital admissions within the medical group. In addition, recent reports in the literature 11, 17 began to suggest that less than 15% of patients hospitalized for asthma in any given year were re-hospitalized in the subsequent year. It was apparent that this targeted approach of case management for repeated hospitalizations failed to adequately identify future treatment failures, and that a population approach was needed with specific case management services provided to high-risk refractory patients by a trained Asthma Specialist.
Based on these observations, the following objectives were established: to improve physician knowledge regarding optimal evidencebased treatment guidelines, to increase patient self-management skills, and to develop a population-based chronic disease management model to assure that all patients receive needed services. The Vice-President of Medical Management and the Medical Director of Quality Improvement presented an overview of these project goals to system physicians at a medical group meeting.
Samples for analyses
Two sources of data were used to compare population characteristics before and after the program implementation. To assess utilization of resources, the population of persons with asthma was identified using an administrative claims database. Inclusion criteria for the study population included patients aged 4-55 years; continuously enrolled from June 1, 1998 through May 31, 1999 for baseline; the followup time frame was from June 1, 1999 through June 30, 2000. Administrative claims were used to examine asthma-related hospital admissions and ED visits per thousand asthmatics.
A medical record audit was conducted to examine recorded compliance with asthma guidelines and documentation practices. 
Statistical analysis
For claims comparisons, baseline and followup data were calculated as events per 1000 for each variable. For medical record data, odds ratios were calculated comparing the number at follow-up to baseline. Confidence intervals were calculated for each ratio, and a chi-square test was used to assess statistical significance of the ratio. For all comparisons, a two-tailed p significance value was computed.
Interventions
Interventions were based on clearly identified obstacles and barriers specific to the AHCs' group practice and on known best practices identified through literature review and participation in the Chicago Asthma Consortium, a citywide asthma advocacy organization. For the most part, development and implementation occurred simultaneously.
Patient registry.
A patient registry was created in order to develop our population-driven program. The population of persons with asthma was identified using an administrative claims database. Inclusion criteria were patients aged 4-55 years, one or more inpatient admissions or ED visits with a primary or secondary diagnosis of asthma (ICD-9 code ϭ 493.00-493.92), and two or more outpatient encounters with an ICD-9 code of 493.00-493.92. Patient information was entered into an ACCESS database that was maintained by the clinical analyst within the quality improvement department and was updated annually. It was used in the process of disseminating patient surveys, educational information, and reminder letters for annual influenza vaccination.
Identification of potential future treatment failures. One of the more significant lessons learned, and published in the literature, has been the realization that, within an asthma population, recent ED use or hospitalizations are poor predictors of future use. Our task force recognized the concerns related to targeting patients by resource utilization or asthma severity based on claims data. The task force investigated several alternative models and decided to use and adapt the Asthma Therapy Assessment Questionnaire (ATAQ). 18 This brief, validated questionnaire is self-administered and was designed to obtain data from patients to assess the level of asthma control and to identify possible disease management barriers. Additional questions were added to ATAQ to assess the patients' perception of the quality of care, their self-rated health status, use of home peak flow meters, and use of specific health services. The baseline questionnaire along with a cover letter was mailed during October and November 1999. A repeat mailing followed the initial mailing if no response was received after three weeks. ATAQ was mailed to asthma patients identified through the registry and included an Education on Asthma Summary Insert (EASI) sheet, highlighting important general asthma self-management strategies. Results of responses were collated until December 1999. In January 2000, physicians received a written summary report of the responses of their patients, including specific management recommendations developed by our task force. During January 2000, all patients that responded to the ATAQ survey were also mailed an EASI sheet that was specific to deficits identified by their ATAQ responses.
Asthma Specialist Case Manager. In September 1999, an Asthma Specialist (case manager) was hired. This individual was a registered nurse with extensive experience with asthma management in both the adult and pediatric populations. Patients were identified and referred for case management by primary care physicians (PCPs) and sought out through weekly review of an inpatient admission database. Criteria for referral included hospitalization for asthma, repeated compliance concerns or significant psychosocial issues. Case management occurred during three types of interactions: telephone calls, office visits and home visits. All patients were telephoned and triaged to determine the potential contribution of environmental factors to their exacerbations. Based upon this triage, home visits for environmental assessments were conducted in conjunction with individual visits. A standardized summary letter was sent to the PCP after any interaction. Within the first year, over 200 patients were contacted, and 75 were entered into this case management program.
In addition to case management, responsibilities of the case manager included developing a standardized patient education checklist to assist office-based nurses in providing education that supported the National Heart, Lung and Blood Institute (NHLBI) guidelines. The team selected these national guidelines as the foundation for provider education primarily on the comprehensive level of supporting evidence provided for each recommendation.
Office-based asthma nurse educators. Each health center identified an office-based nurse to be an on-site resource. With the support of senior management and local administration, the nurses were sent for training using the Red Cross Train the Trainer curriculum beginning in July 1999 and completed by October 1999. They were provided with a standardized curriculum to follow for teaching referred patients. Patient educational materials focused on selfmanagement skills.
Office "par stock" program. A par stock program that ensured office onsite availability of spacers, peak flow meters, and nebulizers was implemented in late 1999. This program allows physicians to directly dispense these types of durable medical equipment at the office, rather than requiring the patient to go to a pharmacy in the midst of an acute asthma exacerbation.
Written home treatment plan. The asthma care task force reviewed several previously existing patient treatment plan templates. Physicians raised several concerns about these plans to the team, including the lack of user friendliness as well as lack of additional teaching potential. Consequently, a new home treatment plan template was developed de novo. This double-ply form included a checklist format for medication instructions, severity classification, reminders for flu vaccination, and general principals of asthma care. Forms were placed in every physician exam room within the organization by November 1999.
Physician education. Physician education had several important components. First, in 1999, medical grand rounds focusing on the NHLBI asthma guidelines were offered at two offcampus venues. Second, in March 2000, an asthma resource binder was sent to all PCPs. This included a copy of the NHLBI guidelines, key recent reference articles, a completed sample patient home treatment plan, a copy of the ATAQ survey with an example of a physician feedback report, and outlines of the roles of the case manager and office-based nurse educators. Third, a new problem-based learning (PBL) method of clinician continuing education was adopted. PBL is an interactive case presentation allowing active participation of the clinicians in the establishment of a diagnosis, assessment, and treatment of the asthma patient presented. The pre-established objectives of a given case include recognition of the following principles of management: (1) asthma is a chronic inflammatory disease of the lungs with variable clinical expression; (2) objective assessment of lung function is important in the management of asthma; (3) asthma home action plans facilitate self-management of asthma; and (4) the use of anti-inflammatory controller therapy is essential in the treatment of all forms of chronic persistent asthma. Other objectives are established as the unique aspects and circumstances of each asthma case are identified. Asthma cases are selected from a library of copyrighted PBL cases and also are generated by our resident certified PBL facilitator. The asthma cases represent all clinical presentations of asthma. One PBL asthma case is presented for a minimum of ninety minutes during a time traditionally allocated for routine staff meetings. At the conclusion of each PBL program, a wrap-up summarization of the case is made with additional questions answered by the PBL facilitator who is a board certified allergist. CME credits are granted to the participants for each PBL program. By March 2000, 70 physicians had participated.
RESULTS
At baseline, 3,486 persons-representing 4.4% of the continuously enrolled medical group population in this age group-were identified as having asthma. Of these, 17.0% were ages 4-9, 21.7% were ages 10-17, and 61.3% were ages 18-55. The age distribution of the population of persons with asthma was similar at baseline and post-program. The ATAQ questionnaire with supplemental questions was mailed to 4,370 individuals identified from the claims database. Of these, 534 were undeliverable, leaving a potential population of 3,836. Of these, 1,340 usable surveys were returned, for a response rate of 34.9%. Table 2 summarizes measures of asthma control as reported in responses to the ATAQ. Among adults, 70% reported that their asthma was well controlled. Yet when questioned about specific areas indicating possible poor control, 34% reported missing work, school or activity, 48% reported awakening at night because of asthma, and 95% reported frequent use of a quick-relief inhaler. The findings for control problems among parents reporting about their children were similar, with the exception that a higher proportion (90%) indicated that their child's asthma was well controlled. In general, self-efficacy barriers were infrequently reported; 95% of the adult respondents and 91% of the pediatric respondents reported believing they were able to take asthma medicine as directed. A high proportion of respondents (92% of adults and 96% of pediatric respondents) believed that medicine is useful in controlling asthma. In the patient/provider communication domain, 76% of adult respondents and 89% of parents made decisions jointly with their doctor or medical care provider. Only 20% of adult respondents had a written treatment plan detailing steps for asthma attacks, and 31% had a written treatment plan on every day management. Written treatment plans were more commonly reported for children, with 62% having a plan for attacks, and 64% having a plan for when not having an attack. Table 3 shows selected processes of care as assessed by chart audits at baseline and postprogram. Documentation of an asthma diagnosis increased from 83.3% of charts at baseline to 98.6% post-program (p Ͻ 0.001). The proportion of charts documenting patient education increased from 15.7% to 26.1% of charts (p Ͻ 0.001), and home action plan documentation increased from 11.1% to 25.4% of charts (p Ͻ 0.001). The documentation of influenza vaccination decreased from 24.2% to 15.0% of charts (p Ͻ 0.001). There were no significant changes in chart documentation of owning a peak flow meter, using a peak flow meter, or smoking cessation advice. Figure 1A shows the decrease in the number of ED visits and hospitalizations per 1000 population before and after implementation of the disease management program. ED visits for asthma decreased 41% from 148 per 1000 to 88 per 1000 (p Ͻ 0.001). Hospitalizations due to asthma decreased 54% from 81 per 1000 to 37 per 1000 (p Ͻ 0.001). In order to assess the potential impact of changes in morbidity experienced by the medical group's patient population during the study period, we examined ED visits and hospitalizations for any diagnosis among persons without asthma. These results are shown in Figure 1B , demonstrating that among the non-asthmatic population, ED visits increased from 109 per 1000 at baseline to 117 per 1000 during follow-up (p Ͻ 0.001), and hospitalizations increased from 54 per 1000 to 59 per 1000 (p Ͻ 0.001).
We estimated the cost savings attributed to the intervention through reduction of ED visits and hospitalization rates from baseline compared to post-program. Based on a conservative, regional average hospital cost per day of $1300 and average ED visit cost of $480, we estimate that a savings of $951,600 was achieved through a reduction in hospitalization, and $382,260 through a reduction in ED visits. These estimated savings were calculated based on the overall change in hospital days and ED visits avoided from baseline to follow-up. Primary costs of the program relate to salary of the case manager, increased pharmacy use, patient education materials, physician and nurse training and administration of the ATAQ survey.
DISCUSSION
Many of the goals of the project were achieved. For example, the findings of this study suggest that this program was associated with a marked reduction in rates of hospitalization and ED utilization. Significant improvement was seen in several essential processes of care: documentation of asthma diagnosis, education, and the use of home action plans. Asthma is one of the most common targets for disease management. Yet, concern about the viability of these programs has been raised, based on potential organizational difficulties, and lack of documented efficacy. 10 Many of the programs described in the published literature targeted high-risk patients identified through utilization. 13, 15, 16 In one study, a populationbased asthma management program in a large health maintenance organization resulted in improved functional status and self-management skills among participants, but no improvements in rates of ED visits and hospitalizations. 14 The focus of the intervention in that study was patient education.
The core components of the AHC program included a mix of patient and provider education and case management. This study was not designed to determine which of these components was the most effective. Yet, the experiences from this project may shed some light on what characteristics are necessary for successful programs.
We believe the greatest determinant of the success of this program was the recognition that improving patient outcomes are the shared goal of the entire system, and not merely that of the clinicians. This recognition was necessary to drive much of the redesign of the care processes and improve the coordination and continuity of care (eg, development of the patient registry, use of the ATAQ survey, implementing feedback processes, case management). Keys to clinician ownership of the program included having clinicians lead the design process, the use of physician champions with both formal and informal influence and the use of rewards and This study has several potential limitations. First, the intervention was multi-factorial, and it is not possible to discern what the most effective components may have been. Second, the use of a pre-post study design limits the validity of a firm conclusion that the intervention program was responsible for the observed changes. The observed changes may have been due to widespread community changes in asthma management, or to changes in the patient population of the medical group. The latter possibility is diminished by the finding that other markers of morbidity in the patient population (ie, total ED visits and hospitalizations) increased among the non-asthmatic population during the study period. The continuous enrollment criteria applied for inclusion in the study group also likely contributes to the conclusion that the improvements were related to the interventions. Lastly, a formal cost-effectiveness analysis was not conducted. This prevented us from establishing a true balance sheet of benefits to cost and, in particular, of establishing a link between specific intervention and cost savings.
In conclusion, this asthma management program was associated with changes in key processes of care and in reduced utilization of ED and hospital services. While other examples of successful asthma programs can be found in the literature, this program's strength lies in its comprehensive design, scale, and significant clinical process redesign that has placed the patient at its center. By raising the standard of asthma care across a population, a comprehensive disease management program has the potential to greatly improve outcomes for persons with asthma.
